Skip to main content

Table 1 Severity Classification Criteria and Therapeutic Strategy for critical COVID-19

From: An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study

Criteria for severe COVID-19

1) SpO2 < 92% at 10 L/min. Oxygen via a reservoir mask

2) Shortness of breath with respiratory rate of > 30/min.

3) Severe dyspnea due to COVID-19 pneumonia

Therapeutic strategy for critical COVID-19 [11]

1) Mechanical ventilator

mode

pressure control

(primary setting)

PEEP

10–15 mmH2O

Driving Pressure

20–25 mmH2O

Respiratory Rate

12–16/min.

2) Antiviral therapy

Remdesivir [12]

10 days

3) Systemic steroid therapy

Dexamethasone [13]

10 days

4) Anticoagulant therapy

UFH with therapeutic dose according to APTT (1.5–2 times as normal)

5) Protection for DVT

Intermittent air compression and elastic stocking

6) Antibiotics

for CAP or secondary bacterial or fungus infection

 

7) Rehabilitation

early intervention by NS, PT and OT

 

8) Nutrition

early intervention via tube feeding or TPN

 

9) Supportive therapy

sedation,catecholamine support etc. via central venous catheter

  1. PEEP Positive end-expiratory pressure, PS Pressure support, UFH Unfractionated heparin, APTT Activated partial thromboplastin time, CAP Community associated pneumonia, NS Nurse, PT Physical therapist, OT Occupational therapist, TPN Total parenteral nutrition